R&D intensity and exports: a study of Indian pharmaceutical firms

Bishwanath Goldar

Innovation and Development, 2013, vol. 3, issue 2, 151-167

Abstract: The export intensity of Indian pharmaceutical firms has increased substantially in the period after 1995 when the new, more restrictive patent regime was introduced in India. The hike in export intensity has been accompanied by an increase in R&D intensity of Indian pharmaceutical firms. The results of the econometric analysis presented in the paper indicate that increased R&D efforts of Indian pharmaceutical firms were responsible in a major way for the observed increase in export intensity. The econometric results suggest that the impact of R&D intensity on exports depends on the level of productivity already reached by the firms.

Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (7)

Downloads: (external link)
http://hdl.handle.net/10.1080/2157930X.2013.828878 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:riadxx:v:3:y:2013:i:2:p:151-167

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/riad20

DOI: 10.1080/2157930X.2013.828878

Access Statistics for this article

Innovation and Development is currently edited by K J Joseph (Editor-in-chief), Cristina Chaminade, Gabriela Dutrénit, Judith Sutz, Tim Turpin and Susan Cozzens

More articles in Innovation and Development from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().